Clinical trial
Acute Human Parvovirus B19 Infection Triggers Immune-Mediated Transient Bone Marrow Failure Syndrome, Extreme Direct Hyperbilirubinemia and Acute Hepatitis in Patients With Hereditary Hemolytic Anemias: Multicenter Pathophysiological Study
NCT04822090 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Human Parvovirus B19 Infection Triggers Immune-Mediated Transient Bone Marrow Failure Syndrome, Extreme Direct Hyperbilirubinemia and Acute Hepatitis in Patients With Hereditary Hemolytic Anemias: Multicenter Pathophysiological Study
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 10, 2018
- Completion date
- February 10, 2024
- Enrollment
- 244 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parvovirus b19 infection